Aptose Biosciences (APTOF, $1.76) was a top loser over the last three months, falling -5 to $1.76 per share. A.I.dvisor analyzed 835 stocks in the Biotechnology Industry for the 3-month period ending May 27, 2025, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend. 789 similar cases when APTOF's price dropped within three months. In out of those 789 cases, APTOF's price went down during the following month. Based on these historical data, the odds of a Downtrend continuation for APTOF are